Tiago Marques Pasithea Therapeutics Corp. (KTTA) insider trading activity

Tiago Marques is Chief Executive Officer of Pasithea Therapeutics Corp.. Currently has a direct ownership of 73,334 shares of KTTA, which is worth approximately $52,800. The most recent transaction as insider was on Nov 28, 2025, when has been sold 33,333 shares (Common Stock) at a price of $0.75 per share, resulting in proceeds of $24,999. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 73.3K

83.33% 3M change

91.05% 12M change

Total Value Held $52,800

Tiago Marques Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 28 2025	BUY Open market or private purchase	$24,999 $0.75 p/Share	33,333 Added 31.25%	73,334 Common Stock
May 12 2025	SELL Open market or private sale	$787 $0.82 p/Share	960 Reduced 2.34%	40,001 Common Stock
Nov 25 2022	BUY Grant, award, or other acquisition	$2,060 $1.03 p/Share	2,000 Added 0.24%	819,206 Common Stock
Nov 23 2022	BUY Grant, award, or other acquisition	$7,350 $1.02 p/Share	7,206 Added 0.87%	817,206 Common Stock
Oct 21 2022	BUY Grant, award, or other acquisition	$5,400 $1.08 p/Share	5,000 Added 0.61%	810,000 Common Stock
Jun 23 2022	BUY Grant, award, or other acquisition	$4,950 $0.99 p/Share	5,000 Added 0.62%	805,000 Common Stock
Dec 20 2021	BUY Grant, award, or other acquisition	-	200,000 Added 20.0%	800,000 Common Stock

Tiago Marques

Chief Executive Officer

Miami Beach, FL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KTTA shares.

Notify only if

Value

Insider Trading

Get notified when an Pasithea Therapeutics Corp. insider buys or sells KTTA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Pasithea Therapeutics Corp.

Track Activities on KTTA

Account